Beth Israel Deaconess
Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy
Investigators reported on how ctDNA, measured using Natera's patient-specific Signatera assays, corresponded to a patient's disease progression and other biomarkers.
Gray Foundation Awards $25M in Cancer Research Grants
The grant recipients will receive up to $5 million each and are led by scientists at institutions including Harvard Medical School and the Cleveland Clinic.
The Singapore-based firm has established a US subsidiary and named distributors to sell its products across Europe, the Middle East, and Asia.
Pancreatic Cancer Liquid Biopsy Test to Be First Product of Harvard Spinout Biomarx Therapeutics
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.